4//SEC Filing
Watkin Jared 4
Accession 0001415889-21-002268
CIK 0000001800other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:07 PM ET
Size
15.4 KB
Accession
0001415889-21-002268
Insider Transaction Report
Form 4
Watkin Jared
Senior Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2021-04-30−17,043→ 0 totalExercise: $44.40From: 2018-02-17Exp: 2027-02-16→ Common Shares (17,043 underlying) - Sale
Common shares without par value
2021-04-30$119.89/sh−85,043$10,195,627→ 59,783 total - Sale
Common shares without par value
2021-04-30$120.02/sh−9,533$1,144,113→ 59,783 total - Exercise/Conversion
Common shares without par value
2021-04-30$59.94/sh+68,000$4,075,920→ 144,826 total - Exercise/Conversion
Option (right to buy
2021-04-30−68,000→ 33,987 totalExercise: $59.94From: 2019-02-16Exp: 2028-02-15→ Common Shares (68,000 underlying) - Exercise/Conversion
Common shares without par value
2021-04-30$44.40/sh+17,043$756,709→ 76,826 total
Holdings
- 602(indirect: By Trust)
Common shares without par value
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.0103 to $120.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.13, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2021.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001645118
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 7:07 PM ET
- Size
- 15.4 KB